Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (151-160 of 544) with videos related to

Pageof 55
Sort By:
Oncotarget|November 29, 2016
Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriersLovisa Odén, Mohammad Akbari, Tasnim Zaman, et al.
Familial Cancer|August 2, 2012
Routine TP53 testing for breast cancer under age 30: ready for prime time?Jeanna M McCuaig, Susan R Armel, Ana Novokmet, et al.
Cancer Causes & Control : CCC|January 12, 2010
Toenail selenium status and DNA repair capacity among female BRCA1 mutation carriersJoanne Kotsopoulos, Zhou Chen, Katherine A Vallis, et al.
Human Genetics|April 7, 2007
The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancerGeorge Zogopoulos, Heidi Rothenmund, Ayelet Eppel, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2008
Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers?Anna Jakubowska, Katarzyna Jaworska, Cezary Cybulski, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 4, 2015
Uninterrupted Sedentary Behavior Downregulates BRCA1 Gene ExpressionRachael Pettapiece-Phillips, Max Kotlyar, Rania Chehade, et al.
Breast Cancer Research and Treatment|January 22, 2008
Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancerJoanne Kotsopoulos, William W Zhang, Shiyu Zhang, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 8, 2011
The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancersDanny Vesprini, Steven A Narod, John Trachtenberg, et al.
Breast Cancer Research : BCR|August 19, 2016
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specificRania Chehade, Rachael Pettapiece-Phillips, Leonardo Salmena, et al.
Gynecologic Oncology|April 15, 2008
Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1Ian Harley, Barry Rosen, Harvey A Risch, et al.
Pageof 55

Showing results (151-160 of 544) with videos related to

Sort By:
Pageof 55
Oncotarget|November 29, 2016
Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriersLovisa Odén, Mohammad Akbari, Tasnim Zaman, et al.
Familial Cancer|August 2, 2012
Routine TP53 testing for breast cancer under age 30: ready for prime time?Jeanna M McCuaig, Susan R Armel, Ana Novokmet, et al.
Cancer Causes & Control : CCC|January 12, 2010
Toenail selenium status and DNA repair capacity among female BRCA1 mutation carriersJoanne Kotsopoulos, Zhou Chen, Katherine A Vallis, et al.
Human Genetics|April 7, 2007
The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancerGeorge Zogopoulos, Heidi Rothenmund, Ayelet Eppel, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2008
Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers?Anna Jakubowska, Katarzyna Jaworska, Cezary Cybulski, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 4, 2015
Uninterrupted Sedentary Behavior Downregulates BRCA1 Gene ExpressionRachael Pettapiece-Phillips, Max Kotlyar, Rania Chehade, et al.
Breast Cancer Research and Treatment|January 22, 2008
Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancerJoanne Kotsopoulos, William W Zhang, Shiyu Zhang, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 8, 2011
The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancersDanny Vesprini, Steven A Narod, John Trachtenberg, et al.
Breast Cancer Research : BCR|August 19, 2016
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specificRania Chehade, Rachael Pettapiece-Phillips, Leonardo Salmena, et al.
Gynecologic Oncology|April 15, 2008
Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1Ian Harley, Barry Rosen, Harvey A Risch, et al.
Pageof 55